Franke Fábio - Hospital de Caridade

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 110 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro) + Carboplatin (carbo) + Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

M. Dzienis, J. Cundom,C.S. Fuentes,A. Spreafico, M.J. Nordlinger, A.V. Pastor, E. Alesi,A. Neki, A.S. Fung, I.P. Figueiredo Lima, P. Oppelt, G.F. da Cunha Junior,F.A. Franke, J. Tseng,A.J. Joshi, J. McCarthy, Y. Sidi,B. Gumuscu, N. Naicker, G. de Castro Jr

International Journal of Radiation Oncology*Biology*Physicsno. 5 (2024): e3-e4

Cited0Views0Bibtex

TROPION-Lung07: Phase III Study of Dato-DXd + Pembrolizumab ± Platinum-Based Chemotherapy As 1L Therapy for Advanced Non-Small-cell Lung Cancer

Isamu Okamoto, Shoichi Kuyama, Nicolas Girard,Shun Lu,Fábio Franke, Ziming Li, Pongwut Danchaivijitr, Ji-Youn Han,Jong-Mu Sun,Shunichi Sugawara, Edward Pan, Natalie Ren, Aiying Chen, Rachana Rajagopalan, Aaron E Lisberg

Future oncology (London, England)no. 37 (2024): 2927-2936

Cited0Views0WOSBibtex

Clinical Outcomes with Perioperative Nivolumab (NIVO) by Nodal Status among Patients (pts) with Stage III Resectable NSCLC: Results from the Phase 3 CheckMate 77T Study

Mariano Provencio,Mark M. Awad,Jonathan Spicer,Annelies Janssens,Fedor Vladimirovich Moiseenko, Yang Gao,Yasutaka Watanabe,Aurelia Alexandru,Florian Guisier,Nikolaj Frost,Fabio A. Franke, Jeroen,Jie He,Fumihiro Tanaka,Shun Lu, Cinthya Coronado Erdmann, Padma Sathyanarayana,Phuong Tran,Vipul Devas,Tina Cascone

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024): LBA8007-LBA8007

Cited0Views0Bibtex

Pembrolizumab Plus Carboplatin and Paclitaxel As First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial

Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes,Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin Alesi, Anterpreet Neki,Andrea S. Fung,Iane Pinto Figueiredo Lima,Peter Oppelt,Geraldo Felicio da Cunha Junior,Barbara Burtness,Fabio Andre Franke,Jennifer E. Tseng,Abhishek Joshi, Joy Mccarthy,Ramona Swaby,Yulia Sidi,Burak Gumuscu, Niroshini Naicker,Gilberto de Castro Jr

JOURNAL OF CLINICAL ONCOLOGYno. 25 (2024)

Cited0Views0WOSBibtex

Heredera Breast Cancer: a Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant Plus the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with Previously Untreated HER2-positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Sherko Kuemmel,Catherine Harper-Wynne,Yeon Hee Park,Fábio Franke,Michelino de Laurentiis,Eva Schumacher-Wulf,Daniel Eiger,Sarah Heeson,Andrés Cardona,Özgür Özyilkan,Flavia Morales-Vàsquez,Ciara Metcalfe,Marc Hafner,Eleonora Restuccia,Joyce O’Shaughnessy

BMC CANCERno. 1 (2024)

Cited0Views0WOSBibtex

Heredera Breast Cancer: Phase III Study of First-Line, Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection ± Giredestrant (GDC-9545) for Estrogen Receptor+, HER2+advanced Breast Cancer

Sherko Kuemmel,Catherine Harper-Wynne,Yeon H. Park,Fabio Franke,Michelino De laurentiis,Eva Schumacher-Wulf,Daniel Eiger,Sarah Heeson,Mahesh Shivhare,Eleonora Restuccia,Joyce O'Shaughnessy

CANCER RESEARCHno. 5 (2023)

Cited0Views0Bibtex

Abstract OT2-03-01: Heredera Breast Cancer: Phase III Study of First-Line, Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection ± Giredestrant (GDC-9545) for Estrogen Receptor+, HER2+ Advanced Breast Cancer

Sherko Küemmel,Catherine Harper-Wynne,Yeon H. Park,Fábio Franke,Michelino De Laurentiis,Eva Schumacher-Wulf,Daniel Eiger,Sarah Heeson,Mahesh Shivhare,Eleonora Restuccia,Joyce O’Shaughnessy

Cancer researchno. 5_Supplement (2023): OT2-01

Cited0Views0Bibtex

1505Tip TROPION-Lung07: A Phase III Trial of Datopotamab Deruxtecan (Dato-Dxd) Plus Pembrolizumab (pembro) with or Without Platinum Chemotherapy (Pt-Ct) As First-Line (1L) Therapy in Advanced/metastatic (adv/met) Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression

I. Okamoto,S. Kuyama,N. Girard, S. Lu,F.A. Franke, E. Pan, N. Ren, A. Chen, E. Oputa,A.E. Lisberg

Annals of Oncology (2023): S847-S848

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn